Facebook Linkedin Twitter
Inside Precision Medicine COVID-19 Returns in 20% of Patients Treated with Paxlovid

Antiviral agents

Antibodies responding to covid-19 coronavirus, illustration
Coronavirus

COVID-19 Returns in 20% of Patients Treated with Paxlovid

Chris Anderson -
0
Image showing the SARS-CoV-2 virus being attacked by a COVID-19 antiviral drug such as molnupiravir
Coronavirus

COVID-19 Antiviral Molnupiravir Linked to SARS-CoV-2 Mutations

Helen Albert -
0
Blood samples in test tubes with blue lids showing HIV test results on the side.
News & Features

Type of HIV Pre-Exposure Prophylaxis Could Influence Cardiovascular Risk

Helen Albert -
0
Intestinal microbiome, medical concept
News & Features

Gut Microbiome’s Surprising Role: Amplifying Risks and Intensifying HIV and EBV Infections

Alisa Kirkin -
0
hepatitis virus
News & Features

Egypt’s Swift Elimination of Hepatitis C: A Model for Success Globally

Kathy Vuksanaj -
0
Woman lying down suffering from symptoms of long covid after COVID-19
Coronavirus

NIH Opens Phase II Clinical Trials on Four Potential Treatments for Long COVID

Chris Anderson -
0
Gloved hand holding COVID-19 vaccine in syringe on a background of SARS-CoV-2 particles
Coronavirus

Stem Cells Show SARS-CoV-2’s Different Effects In Heart and Lungs

Malorye Branca -
0
Electron microscopy virus visualization. COVID-19
Coronavirus

Magnolia Tree Bark Compound Inhibits SARS-CoV-2 Replication in Some Cells

Chris Anderson -
0
Green and blue coronavirus cells under magnification intertwined with DNA cell structure
Coronavirus

Broad-Spectrum Antivirals Could Stop Pandemics

Anita Chakraverty -
0
Woman using a nasal spray
Coronavirus

Finnish Researchers Develop Nasal Spray That Protects against COVID

Chris Anderson -
0
123Page 1 of 3

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine